|
|
|
Volumn 39, Issue 3, 1994, Pages 185-192
|
|
Development of single-agent chemotherapy regimens for gestational trophoblastic disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHORIONIC GONADOTROPIN BETA SUBUNIT;
DACTINOMYCIN;
FOLINATE CALCIUM;
METHOTREXATE;
CANCER CHEMOTHERAPY;
CHORIOCARCINOMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GONADOTROPIN BLOOD LEVEL;
HUMAN;
HYDATIDIFORM MOLE;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG METASTASIS;
PHASE 2 CLINICAL TRIAL;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
REMISSION;
TROPHOBLASTIC DISEASE;
VAGINA CANCER;
WORLD HEALTH ORGANIZATION;
CHORIONIC GONADOTROPIN;
CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DACTINOMYCIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
LEUCOVORIN;
METHOTREXATE;
NEOPLASM STAGING;
PEPTIDE FRAGMENTS;
PREGNANCY;
PROGNOSIS;
RISK FACTORS;
TREATMENT FAILURE;
TROPHOBLASTIC NEOPLASMS;
UTERINE NEOPLASMS;
VACUUM EXTRACTION, OBSTETRICAL;
|
|
EID: 0028265659
PISSN: 00247758
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (0)
|
